Search
for
Sort by
Research 511–540 of 890
- Plerixafor Engages β-Arrestin-Dependent CXCR4 Signaling to Promote Melanogenesis via β-Catenin-MITF Activation
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- CD34 <sup>+</sup> cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis
- Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
- Stress-induced sympathetic hyperactivation drives hair follicle necrosis to trigger autoimmunity
- Flavonoid 4,4′-dimethoxychalcone selectively eliminates senescent cells via activating ferritinophagy
- Editors’ Picks
- Alk1 acts in non-endothelial VE-cadherin+ perineurial cells to maintain nerve branching during hair homeostasis
- 078 The transmembrane protein LRIG1 regulates receptor tyrosine kinases in skin development and homeostasis
- The influence of interferon on healthy and diseased skin
- Toll-Like Receptor Function in Acute Wounds
- Resident Memory T Cells in Autoimmune Skin Diseases
- Pathomechanisms of immune-mediated alopecia
- PPAR-<i>γ</i> Agonists and Their Role in Primary Cicatricial Alopecia
- Tumour Necrosis Factor Alpha, Interferon Gamma and Substance P Are Novel Modulators of Extrapituitary Prolactin Expression in Human Skin
- Immunology of alopecia areata
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle
- The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
- What is behind the ‘swarm of bees’ in alopecia areata
- Dermal lymphatic dilation in a mouse model of alopecia areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target
- Pharmacological Activity of Cepharanthine
- Direct Reprograming of Mouse Fibroblasts into Dermal Papilla Cells via Small Molecules
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease